Respiratory syncytial virus (RSV ... has been based on moderate to complex techniques performed in a laboratory (cell culture, nucleic acid amplification and immunofluorescence assays); however ...

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and who ...

Hybridoma cells with functional HGPRT enzyme can survive and grow ... prevention and treatment of respiratory syncytial virus and COVID-19 Organ transplant: rejection prevention of kidney, liver, lung ...

The study assessed 16 different virus-cell combinations that resulted in ... Hendra and respiratory syncytial virus -- also incorporate a mixed-shape infection strategy, the researchers note.

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus ... and specific T-cell immunity compared to ...

Respiratory syncytial virus (RSV) infections are the leading cause of viral death in infants, although RSV-related mortality has decreased since the development and approval of prophylactic ...

RESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products ...

Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum of respiratory illnesses in infants and young children that may lead to hospitalisations and a substantial number of outpatient visits ...

Worldwide, respiratory syncytial virus (RSV ... Testing for RSV Traditional microbiologic methods of diagnosis include cell culture, nucleic acid-amplification tests and immunofluorescence.